These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30718399)

  • 1. Inositol hexakisphosphate kinase 3 promotes focal adhesion turnover via interactions with dynein intermediate chain 2.
    Rojas T; Cheng W; Gao Z; Liu X; Wang Y; Malla AP; Chin AC; Romer LH; Snyder SH; Fu C
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3278-3287. PubMed ID: 30718399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol Hexakisphosphate Kinase-3 Regulates the Morphology and Synapse Formation of Cerebellar Purkinje Cells via Spectrin/Adducin.
    Fu C; Xu J; Li RJ; Crawford JA; Khan AB; Ma TM; Cha JY; Snowman AM; Pletnikov MV; Snyder SH
    J Neurosci; 2015 Aug; 35(31):11056-67. PubMed ID: 26245967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal migration is mediated by inositol hexakisphosphate kinase 1 via α-actinin and focal adhesion kinase.
    Fu C; Xu J; Cheng W; Rojas T; Chin AC; Snowman AM; Harraz MM; Snyder SH
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2036-2041. PubMed ID: 28154132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of inositol hexakisphosphate kinase 1 (IP6K1) reduces cell migration and invasion, conferring protection from aerodigestive tract carcinoma in mice.
    Jadav RS; Kumar D; Buwa N; Ganguli S; Thampatty SR; Balasubramanian N; Bhandari R
    Cell Signal; 2016 Aug; 28(8):1124-36. PubMed ID: 27140681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositol Hexakisphosphate Kinase-2 in Cerebellar Granule Cells Regulates Purkinje Cells and Motor Coordination via Protein 4.1N.
    Nagpal L; Fu C; Snyder SH
    J Neurosci; 2018 Aug; 38(34):7409-7419. PubMed ID: 30006360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inositol hexakisphosphate kinase 1 (IP6K1) activity is required for cytoplasmic dynein-driven transport.
    Chanduri M; Rai A; Malla AB; Wu M; Fiedler D; Mallik R; Bhandari R
    Biochem J; 2016 Oct; 473(19):3031-47. PubMed ID: 27474409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of polymorphic variation of inositol hexakisphosphate kinase 3 (IP6K3) gene promoter to the susceptibility to late onset Alzheimer's disease.
    Crocco P; Saiardi A; Wilson MS; Maletta R; Bruni AC; Passarino G; Rose G
    Biochim Biophys Acta; 2016 Sep; 1862(9):1766-73. PubMed ID: 27345265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol hexakisphosphate kinase-2 determines cellular energy dynamics by regulating creatine kinase-B.
    Nagpal L; Kornberg MD; Albacarys LK; Snyder SH
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33547244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of dynein intermediate chain 2 to paxillin controls focal adhesion dynamics and migration.
    Rosse C; Boeckeler K; Linch M; Radtke S; Frith D; Barnouin K; Morsi AS; Hafezparast M; Howell M; Parker PJ
    J Cell Sci; 2012 Aug; 125(Pt 16):3733-8. PubMed ID: 22553211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inositol Hexakisphosphate Kinase 3 Regulates Metabolism and Lifespan in Mice.
    Moritoh Y; Oka M; Yasuhara Y; Hozumi H; Iwachidow K; Fuse H; Tozawa R
    Sci Rep; 2016 Aug; 6():32072. PubMed ID: 27577108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Inositol Pyrophosphate Biosynthetic Enzymes in Metabolic Diseases.
    Mukherjee S; Haubner J; Chakraborty A
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32204420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1.
    Rao F; Xu J; Fu C; Cha JY; Gadalla MM; Xu R; Barrow JC; Snyder SH
    Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1773-8. PubMed ID: 25617365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic conformational changes in the FERM domain of FAK are involved in focal-adhesion behavior during cell spreading and motility.
    Papusheva E; Mello de Queiroz F; Dalous J; Han Y; Esposito A; Jares-Erijmanxa EA; Jovin TM; Bunt G
    J Cell Sci; 2009 Mar; 122(Pt 5):656-66. PubMed ID: 19208768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF Enhances the Migration of MSCs in Neural Differentiation by Regulating Focal Adhesion Turnover.
    Wang H; Wang X; Qu J; Yue Q; Hu Y; Zhang H
    J Cell Physiol; 2015 Nov; 230(11):2728-42. PubMed ID: 25820249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of novel isoform-selective IP6K1 inhibitors.
    Wormald MM; Ernst G; Wei H; Barrow JC
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126628. PubMed ID: 31445853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IP6K structure and the molecular determinants of catalytic specificity in an inositol phosphate kinase family.
    Wang H; DeRose EF; London RE; Shears SB
    Nat Commun; 2014 Jun; 5():4178. PubMed ID: 24956979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetyl-D-glucosamine kinase interacts with dynein light-chain roadblock type 1 at Golgi outposts in neuronal dendritic branch points.
    Islam MA; Sharif SR; Lee H; Seog DH; Moon IS
    Exp Mol Med; 2015 Aug; 47(8):e177. PubMed ID: 26272270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revealing the three dimensional architecture of focal adhesion components to explain Ca
    Chang SJ; Chen YC; Yang CH; Huang SC; Huang HK; Li CC; Harn HI; Chiu WT
    Biochim Biophys Acta Gen Subj; 2017 Mar; 1861(3):624-635. PubMed ID: 28063985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells.
    Tilghman RW; Slack-Davis JK; Sergina N; Martin KH; Iwanicki M; Hershey ED; Beggs HE; Reichardt LF; Parsons JT
    J Cell Sci; 2005 Jun; 118(Pt 12):2613-23. PubMed ID: 15914540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
    Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
    Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.